New neuromodulation device may help prevent migraine

If your bank account balance looks nail-bitingly low and you won't get paid for days, you might agonize over every dollar you spend. Maybe you'll scrutinize grocery-store ads more closely than usual or brew...

OncoCyte Launches NSCLC Stratification Test, Looks beyond Lung Cancer

OncoCyte president and CEO Ron (Ronnie) Andrews discussed the company's recent acquisitions and expansion of its diagnostics menu with GEN Edge . . . The post OncoCyte Launches NSCLC Stratification Test, Looks beyond Lung Cancer...

Analysis: Broad Institute Loses Appeal on European CRISPR Patent

A decision from the Boards of Appeal at the European Patent Office has revoked the claim of the Broad Institute to general patents on CRISPR/Cas9 gene editing technology, strengthening the position of its opponent...

€6M Seed Round to Develop First Urine Test for Kidney Cancer

The Swedish biotech Elypta has raised a seed round worth €6.1M to fund a clinical trial of a urine test for signs of recurrent kidney cancer, which could improve patient follow-up after surgery. The seed...

UK biotech records third highest year for investment, study finds – European Pharmaceutical Review

Research has revealed that the biotechnology industry was worth £1.3 billion in 2019, marking its third-highest year for investment. New research has shown that the UK biotechnology sector was worth £1.3 billion in 2019,...

This Company is Using Moths to Make Vaccines

Madrid-based company Algenex is using moths as natural bioreactors to improve the speed and scalability of making proteins used in vaccines and diagnostics. Mission: To harness nature for simple, scalable, and cost-efficient recombinant protein manufacture. ADVERTISEMENT...

Mycoplasma in Cell Culture: Fighting Back with Rapid Detection Kits

insights from industryPatrick SwanCheif Operating OfficerGold Biotechnology An interview with Patrick Swan, COO of Gold Biotechnology, discussing the effects of mycoplasma contamination on cell cultures and the development of rapid detection kits that provide answers...

“Skeleton Key” T-Cell Receptor Works across Multiple Cancer Types

Anticancer T-cell therapy has a lot in common with lock picking, a painstaking business that often ends in frustration. Every cancer, like every lock, presents a unique challenge. But what if there were such...

Maglab scientists capture molecular maps of animal tissue with unprecedented detail

Credit: Stephen Bilenky We’ve all heard, and seen, how a picture paints a thousand words. Now, in a scientific twist on that saying, researchers at the Florida...

A two-drug combo that halts growth of cancer cells discovered

UT Southwestern Simmons Cancer Center researchers have discovered a two-drug combo that halts the growth of cancer cells that carry HER2 mutations. The findings, published today in the journal Cancer Cell, were prompted by the...

Stay connected

47,412FollowersFollow
14,700SubscribersSubscribe

Recent posts

Random article